Overview of Quebec’s RNA Therapy Sector

October 15, 2025

Quebec’s Therapeutic RNA ecosystem as of Spring 2025

AReNA presents an overview of Quebec’s RNA Therapy Sector, aimed at mapping Quebec’s ecosystem, identifying its strengths, and highlighting its potential contributions and international impact.

Download the Report (PDF)

Summary

Introduction & Context
An ecosystem built on three complementary sectors
World-class public research
Strategic Consolidation of the Industrial Sector
Tangible outcomes and rapidly growing expertise
Conclusion

The results presented are primarily based on data collected by the consulting firm Innovitech as part of a study conducted in spring 2025. They have been supplemented with additional information obtained directly from the various stakeholders within the ecosystem

Note : This study was made possible thanks to the financial support of the Ministry of Economy, Innovation and Energy (MEIE) and the CQDM.
The methodology employed is based on the aggregation and analysis of multimodal datasets, emails, individual interviews, and surveys.

Industry news

press release from moderna on vaccine factory background

September 19, 2025

Médicament Québec Awards Two Major Grants for RNA Innovation with Financial Support from the Ministère de l’Économie, de l’Innovation et de l’Énergie (MEIE)

Learn more

June 17, 2025

MedicalExpo E-Magazine article highlights AReNA’s panelists at 2025 EFFERVESCENCE on RNA Therapies: From Pandemic Vaccines to Tomorrow’s Medicine.

Learn more

May 8, 2025

The creation of a biomanufacturing services platform to boost expertise in Quebec and accelerate the development of RNA therapies

Learn more

June 6, 2024

Overview of Quebec’s RNA Therapy Sector

Quebec’s Therapeutic RNA ecosystem as of Spring 2025

Summary

Industry news

Moderna Announces First Made-in-Canada mRNA Vaccines Delivered to Canadian Provinces and Territories

The Future of RNA Therapies: Amid Uncertainty, Quebec Emerges as a Hub for RNA Innovation.

CASTL Launches Pilot Edition of mRNA/mRNA-LNP Biomanufacturing Training – October 1–3, 2025 | Montreal

The IRCM’s Martin Sauvageau talks to Radio-Canada : End of American Funding for mRNA Vaccines

Citeline podcast episode looks at the state of RNA therapeutics with Novotech’s Tom Hickey

Epitopea Expands its Clinical Development and Research Capabilities as it Accelerates to the Clinic

Interest for RNA Therapy Deals Keeps Growing Among Big Pharmaceuticals

Médicament Québec Awards Two Major Grants for RNA Innovation with Financial Support from the Ministère de l’Économie, de l’Innovation et de l’Énergie (MEIE)

AReNA shines at BIO 2025

Eli Lilly and Company to Acquire Verve Therapeutics for Up to $1.3 Billion

AReNA sponsors Rendez-vous Québec at the launch of the BIO International Convention

Pharmaceutiques Magazine spotlights Quebec, driving force for North America’s RNA Sector

DirectIndustry’s take on AReNA, Quebec’s Ambitious Plan to Become a Global RNA Therapeutics Leader

MedicalExpo E-Magazine article highlights AReNA’s panelists at 2025 EFFERVESCENCE on RNA Therapies: From Pandemic Vaccines to Tomorrow’s Medicine.

D2R et AReNA put RNA experts forward at the 92nd ACFAS Congress

AReNA’s expert panel and networking breakfast energize EFFERVESCENCE conference in Montreal

Panagiotis Prinos appointed as Director of Réseau DePTAQ

The AReNA breakfast series presents the CELLULE and the RNA valorisation and entrepreneurship team.

CASTL and the DePTAQ Network present their initiative during AReNA’s breakfast event at IRCM

Jean-Pierre Perreault is elected as Rector of Université de Sherbrooke

Two panelists represent AReNA at Leyton Connect’s 5-to-7

AReNA attended FISQ

AReNA attends CASTL’s Open Door Day

Epitopea closes their $31 million pre-Series A financing.

Congratulations to the Nobel Prize winners in Medicine!

Congratulations to the 23 recipients of the D2R funding programs

The creation of training programs to meet the needs of the RNA therapeutics industry

The creation of a biomanufacturing services platform to boost expertise in Quebec and accelerate the development of RNA therapies

A new initiative to stimulate innovation and entrepreneurship in the RNA therapy sector in Quebec

Quebec Launches AReNA to Become a Global Leader in RNA Therapies

A group of partners are launching the CELLULE to accelerate the development of RNA therapies in Quebec

The long-overlooked molecule that will define a generation of science

Overview of Quebec’s RNA Therapy Sector

Quebec’s Therapeutic RNA ecosystem as of Spring 2025

Summary

Industry news

Moderna Announces First Made-in-Canada mRNA Vaccines Delivered to Canadian Provinces and Territories

The Future of RNA Therapies: Amid Uncertainty, Quebec Emerges as a Hub for RNA Innovation.

CASTL Launches Pilot Edition of mRNA/mRNA-LNP Biomanufacturing Training – October 1–3, 2025 | Montreal

The IRCM’s Martin Sauvageau talks to Radio-Canada : End of American Funding for mRNA Vaccines

Citeline podcast episode looks at the state of RNA therapeutics with Novotech’s Tom Hickey

Epitopea Expands its Clinical Development and Research Capabilities as it Accelerates to the Clinic

Interest for RNA Therapy Deals Keeps Growing Among Big Pharmaceuticals

Médicament Québec Awards Two Major Grants for RNA Innovation with Financial Support from the Ministère de l’Économie, de l’Innovation et de l’Énergie (MEIE)

AReNA shines at BIO 2025

Eli Lilly and Company to Acquire Verve Therapeutics for Up to $1.3 Billion

AReNA sponsors Rendez-vous Québec at the launch of the BIO International Convention

Pharmaceutiques Magazine spotlights Quebec, driving force for North America’s RNA Sector

DirectIndustry’s take on AReNA, Quebec’s Ambitious Plan to Become a Global RNA Therapeutics Leader

MedicalExpo E-Magazine article highlights AReNA’s panelists at 2025 EFFERVESCENCE on RNA Therapies: From Pandemic Vaccines to Tomorrow’s Medicine.

D2R et AReNA put RNA experts forward at the 92nd ACFAS Congress

AReNA’s expert panel and networking breakfast energize EFFERVESCENCE conference in Montreal

Panagiotis Prinos appointed as Director of Réseau DePTAQ

The AReNA breakfast series presents the CELLULE and the RNA valorisation and entrepreneurship team.

CASTL and the DePTAQ Network present their initiative during AReNA’s breakfast event at IRCM

Jean-Pierre Perreault is elected as Rector of Université de Sherbrooke

Two panelists represent AReNA at Leyton Connect’s 5-to-7

AReNA attended FISQ

AReNA attends CASTL’s Open Door Day

Epitopea closes their $31 million pre-Series A financing.

Congratulations to the Nobel Prize winners in Medicine!

Congratulations to the 23 recipients of the D2R funding programs

The creation of training programs to meet the needs of the RNA therapeutics industry

The creation of a biomanufacturing services platform to boost expertise in Quebec and accelerate the development of RNA therapies

A new initiative to stimulate innovation and entrepreneurship in the RNA therapy sector in Quebec

Quebec Launches AReNA to Become a Global Leader in RNA Therapies

A group of partners are launching the CELLULE to accelerate the development of RNA therapies in Quebec

The long-overlooked molecule that will define a generation of science

Stay up to date with the latest news on RNA therapies